Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Testing Board (TEST) Message Board

Mentor Capital, Inc. (OTC Markets: MNTR) announced

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 28537
Posted On: 11/19/2012 12:15:03 PM
Avatar
Posted By: testuser
Mentor Capital, Inc. (OTC Markets: MNTR) announced it hasexecuted a Letter of Intent with Nanovega, Inc. for $6 Million to fund theproduction scale up of its ultra-small synthetic antibodies. These nano-scalemolecules are approximately one-tenth the size of most alternative cancerdelivery bio-markers.  The small sizeallows the nano-bodies to slip throughout solid tumors instead piling up at thesurface as is often currently encountered in cancer treatment. Marek Malecki, MD, PhD, President of Nanovega Inc., looksahead, “We are enthusiastic about the financial support provided by MentorCapital. With intellectual property protected [9 patents and applications] we look to scale up production of ourunique synthetic antibodies.”  Thenano-bodies are already produced for use by outside researchers and designedfor multiple diagnostic and therapeutic applications.  Mentor Capital CEO, Chester Billingsley, adds, “We areespecially intrigued by Nanovega’s ability to tag cancer cells or fragmentscirculating in the blood with ultra-small metal atoms.”  The metal nano-tags allow the cancer cells tobe separated out using a magnetic field. The separated cancer cells may then be quickly grown and tested outsidethe body to pre-determine the most effective chemotherapy to prescribe.    About Mentor Capital:  By acquisition or stock purchase, MentorCapital, Inc. seeks to invest in leading companies that reduce the cost ofmedical treatments especially in the fight against cancer. Additional importantinformation is presented at:  www.MentorCapital.comForward Looking Statements, Safe Harbor and RiskDescriptions are Incorporated by Reference from the MNTR Company Web Siteabove. For further information contact: Chester Billingsley, CEO                    Mentor Capital, Inc. (760) 788 - 4700 


(0)
(0)




Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us